| Michael Joseph Scolieri, MD | |
|
885 S Sawburg Rd, Ste 105, Alliance, OH 44601-5905 | |
| (330) 823-1112 | |
| (330) 823-1139 |
| Full Name | Michael Joseph Scolieri |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 27 Years |
| Location | 885 S Sawburg Rd, Alliance, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679557011 | NPI | - | NPPES |
| 340020570 | Other | OH | RAILROAD MEDICARE |
| 2240793 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 35071 (Ohio) | Primary |
| 2088F0040X | Urology - Female Pelvic Medicine And Reconstructive Surgery | 35-071577 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salem Regional Medical Center | Salem, OH | Hospital |
| Surgical Hospital At Southwoods | Youngstown, OH | Hospital |
| St Elizabeth Youngstown Hospital | Youngstown, OH | Hospital |
| Alliance Community Hospital | Alliance, OH | Hospital |
| East Liverpool City Hospital | East liverpool, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comprehensive Urology Institute Inc | 9638438245 | 4 |
News Archive
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in modern drug development at the Supply Side West Conference in Las Vegas, 8-9 of November.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.
It's sad but true. Celebrity groundhog Punxsutawney Phil of PA and his relatives accurately predict the end or extension of winter only 39 percent of the time according to the United States National Climate Center.
› Verified 9 days ago
| Entity Name | Comprehensive Urology Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750807640 PECOS PAC ID: 9638438245 Enrollment ID: O20180104001432 |
News Archive
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in modern drug development at the Supply Side West Conference in Las Vegas, 8-9 of November.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.
It's sad but true. Celebrity groundhog Punxsutawney Phil of PA and his relatives accurately predict the end or extension of winter only 39 percent of the time according to the United States National Climate Center.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Joseph Scolieri, MD 7790 Cedar Park Dr, Canfield, OH 44406-7700 Ph: (330) 702-1860 | Michael Joseph Scolieri, MD 885 S Sawburg Rd, Ste 105, Alliance, OH 44601-5905 Ph: (330) 823-1112 |
News Archive
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in modern drug development at the Supply Side West Conference in Las Vegas, 8-9 of November.
Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure. Amturnide combines the only approved direct renin inhibitor worldwide, Tekturna (aliskiren), with the widely used calcium channel blocker amlodipine and the diuretic hydrochlorothiazide (HCTZ).
Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.
It's sad but true. Celebrity groundhog Punxsutawney Phil of PA and his relatives accurately predict the end or extension of winter only 39 percent of the time according to the United States National Climate Center.
› Verified 9 days ago
Bradford Thomas Black, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 885 S Sawburg Rd, Suite 105, Alliance, OH 44601 Phone: 330-823-1112 Fax: 330-823-1139 |